Related Experiment Video
Updated: Sep 5, 2025
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.7K
Management of recurrent retroperitoneal sarcomas
Caroline C H Siew1, Kenneth Cardona2, Winan J van Houdt3
1Division of Surgical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 11 Jalan Tan Tock Seng, 308433, Singapore.
Summary
Recurrent retroperitoneal sarcomas are rare and challenging to manage due to diverse presentations. This review offers insights into understanding and managing these complex cases, balancing disease control with quality of life.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Recurrent retroperitoneal sarcomas present a complex clinical challenge due to varied patient characteristics, treatment histories, and diverse recurrence patterns.
- Histologic subtype significantly influences recurrence patterns in retroperitoneal sarcomas, impacting management strategies.
- While surgical resection can improve survival in select cases, oncological outcomes for recurrent disease are generally inferior to primary tumors.
Approach:
- This review synthesizes current knowledge on the understanding and management of recurrent retroperitoneal sarcomas.
- It examines various treatment modalities, including surgical resection, local ablative therapy, radiation, and systemic therapy.
- The review emphasizes balancing disease control with patient morbidity and quality of life.
Key Points:
- Management of recurrent retroperitoneal sarcomas requires a multidisciplinary approach tailored to individual patient factors and tumor characteristics.
- Surgical resection offers survival benefits in select patients but is associated with poorer outcomes compared to primary tumors.
- For unresectable disease, options include local therapies, radiation, systemic treatments, and occasionally palliative surgery.
Conclusions:
- Effective management of recurrent retroperitoneal sarcomas necessitates a careful balance between achieving disease control and preserving patient quality of life.
- Further research is needed to optimize treatment strategies and improve long-term outcomes for patients with these rare malignancies.
- This review provides guidance for clinicians facing the complexities of recurrent retroperitoneal sarcoma management.
